Novel and innovative product and production processes for pharmaceuticals
As novel products and processes are rapidly expanding in the pharma industry, we would like to share with you various new developments in the fields of Advanced Therapy Medicinal Products and insights from technology providers. With topics such as personalized medicine, modular production technology and increasing levels of automation and integration for biosimilar production, we hope to be able to inform you about exciting new trends within the pharmaceutical industry in the Netherlands.
This event will be organized at Kiadis Pharma, based in Amsterdam South-East.
For the Young Professionals there will be a parallel program where PME-Progress and Yxion will discuss topics that are relevant for the new generation of professionals.
The regular program will close with drinks followed by a dinner (for those interested, at additional costs).
Attention: No parking space available. Please use public transport (Station Holendrecht) and P+R Arena.
|Event Date||05-Nov-2019 13.00|
Introduction to ISPE - by René van Opstal - Chair ISPE Netherlands Introduction to Kiadis, cell therapy supply chain, and recent evolutions in the company - by Dirk de Naeyer
Presentation Kiadis Pharma
Cell therapy process development and commercialization - setting standards for an emerging field - by Mathieu Streefland
Presentation GE Healthcare Life Sciences
Addressing complexities in modular cell therapy manufacturing workflows - by Gonçalo Regalo
YP presentation Yxion
Presentation Miltenyi Biotech
The future of GMP cell manufacturing - by Martha Elia Luevano Salinas
YP presentation Progress PME
Feasibility of a biosimilar plant
An interactive Q&A session on the development of new technology for pharma and the challenges encountered - by Ard Tijsterman
End of program
Drinks and YP event
During the drinks various companies will “pitch” themselves to the young professionals present as a way of introducing themselves to the next generation of pharma professionals
Requires separate indication at registration - at additional costs
Field Applications Specialist Cell Therapy – GE Healthcare & Life Sciences
Yxion Pharma and Healthcare